相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of clobetasol spray: Factors beyond patient compliance
Tina Bhutani et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2012)
What is new in topical therapy for psoriasis?
K. Reich et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
In touch with psoriasis: topical treatments and current guidelines
G. Murphy et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the international psoriasis council
P. C. M. van de Kerkhof et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Topical treatment of psoriasis
Philip M. Laws et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Topical corticosteroids in psoriasis: strategies for improving safety
E. J. Horn et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha
Joana Camara et al.
FIBROGENESIS & TISSUE REPAIR (2010)
VITAMIN D ANALOGUE-BASED THERAPIES FOR PSORIASIS
J. L. O'Neill et al.
DRUGS OF TODAY (2010)
Topical Clobetasol Propionate in the Treatment of Psoriasis A Review of Newer Formulations
Steven R. Feldman et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2009)
Calcipotriene/betamethasone in the treatment of psoriasis: a review article
Rosita Saraceno et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Treatment of severe scalp psoriasis: From the Medical Board of the National Psoriasis Foundation
C. Stanley Chan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis
Rafael de Cid et al.
NATURE GENETICS (2009)
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Mauro Perretti et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Annexin-A1: a pivotal regulator of the innate and adaptive immune systems
F. D'Acquisto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
Kristiina M. Huttunen et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: A phase II study
Colin Buckley et al.
DERMATOLOGY (2008)
Cushing-Syndrom mit lebensbedrohlichen infektiologischen Komplikationen
S. Kloehn et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial
Gregor B. E. Jemec et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Psoriasis: consensus on topical therapies
P. C. M. van de Kerkhof et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Erk5 Controls Slug Expression and Keratinocyte Activation during Wound Healing
Valerie Arnoux et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Psoriasis 2 - Current and future management of psoriasis
Alan Menter et al.
LANCET (2007)
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
A. Nast et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Pathogenesis and therapy of psoriasis
Michelle A. Lowes et al.
NATURE (2007)
Dermal and transdermal drug delivery systems: Current and future prospects
MB Brown et al.
DRUG DELIVERY (2006)
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
EM Sternberg
NATURE REVIEWS IMMUNOLOGY (2006)
A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis
CEM Griffiths et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2006)
Glucocorticoid therapy-induced skin atrophy
S Schoepe et al.
EXPERIMENTAL DERMATOLOGY (2006)
Understanding the IL-23-IL-17 immune pathway
BS McKenzie et al.
TRENDS IN IMMUNOLOGY (2006)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis
L Stein
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Corticosteroids: Options in the era of steroid-sparing therapy
J Del Rosso et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-ß1 -: Potential role in idiopathic pulmonary fibrosis
BC Willis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Psoriasis treatment: traditional therapy
M Lebwohl et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Glucocorticoids for human skin: New aspects of the mechanism of action
M Schafer-Korting et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2005)
Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment
CL Carroll et al.
ARCHIVES OF DERMATOLOGY (2005)
Tacrolimus ointment is effective for facial and intertriginous psoriasis
M Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Development of a new formulation combining calcipotriol and betamethasone dipropionate in an ointment vehicle
L Simonsen et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2004)
Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor
I Rogatsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A case of generalized pustular psoriasis treated with topical tacrolimus
A Ishiko et al.
ARCHIVES OF DERMATOLOGY (2003)
The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1:: Molecular mechanisms for gene repression
K De Bosscher et al.
ENDOCRINE REVIEWS (2003)
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
GD Weinstein et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Chromatin remodeling by nuclear receptors
PB Hebbar et al.
CHROMOSOMA (2003)
The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment
J Traulsen et al.
DERMATOLOGY (2003)
Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment:: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases
Y Oishi et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Cyclooxygenase isozymes and their gene structures and expression
T Tanabe et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase
A Hafezi-Moghadam et al.
NATURE MEDICINE (2002)
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
HM Reichardt et al.
EMBO JOURNAL (2001)
A pilot study to determine, the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy
K Kaidbey et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2001)
Cross-talk between pro-inflammatory transcription factors and glucocorticoids
IM Adcock et al.
IMMUNOLOGY AND CELL BIOLOGY (2001)
Inhibition of cytosolic phospholipase A2 by annexin I -: Specific interaction model and mapping of the interaction site
SW Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin
L Kolbe et al.
SKIN RESEARCH AND TECHNOLOGY (2001)
Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis
JYM Koo et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2001)
Management of scalp psoriasis - Guidelines for corticosteroid use in combination treatment
CJM van der Vleuten et al.
DRUGS (2001)
Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone
L Pujols et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Molecular mechanisms regulating protein turnover in muscle
SR Price et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
CREB is involved in mouse annexin A1 regulation by cAMP and glucocorticoids
F Antonicelli et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Tazarotene plus UVB phototherapy in the treatment of psoriasis
JYM Koo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Novel mechanism of steroid action in skin through glucocorticoid receptor monomers
N Radoja et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo -: Characterisation of drugs with an increased benefit-risk ratio
C Schackert et al.
BIODRUGS (2000)
分享论文
